Form 4 Tracker
Mary Kay Ladone

Director · 3 filings · Latest: Sep 8, 2026

Bioventus Inc.
Inogen Inc
KESTRA MEDICAL TECHNOLOGIES, LTD.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KMTS
Mary Kay LadoneDirectorSep 8, 2026
Sale
$25.203,908$98.5K37,507
KMTS
Ladone Mary Kay—Sep 8, 2026
Proposed Sale
$25.203,908$98.5K—
BVS
Mary Kay LadoneDirectorJun 2, 2026
Option Exercise
$0.0032,282—111,263